- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 3.36M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $26.41M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $37.34M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $30.23M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $41.3M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $44.93M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $39.49M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $78.41M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $76.67M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $9.17M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $15.76M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 879K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$28.13M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $82.77M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $96.16M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$35.75 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$35.75 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $19.09M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $9.78M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$31.42M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$31.12M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $5.95M |
| Revenue | Q1 2025 · Mar 31, 2024 | $8.77M |